Correlation Between Day One and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both Day One and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Inozyme Pharma, you can compare the effects of market volatilities on Day One and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Inozyme Pharma.
Diversification Opportunities for Day One and Inozyme Pharma
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Day and Inozyme is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Day One i.e., Day One and Inozyme Pharma go up and down completely randomly.
Pair Corralation between Day One and Inozyme Pharma
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Inozyme Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 1.41 times less risky than Inozyme Pharma. The stock trades about -0.01 of its potential returns per unit of risk. The Inozyme Pharma is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 141.00 in Inozyme Pharma on August 23, 2024 and sell it today you would earn a total of 126.00 from holding Inozyme Pharma or generate 89.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Inozyme Pharma
Performance |
| Timeline |
| Day One Biopharmaceu |
| Inozyme Pharma |
Day One and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Inozyme Pharma
The main advantage of trading using opposite Day One and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
| Inozyme Pharma vs. Kiora Pharmaceuticals | Inozyme Pharma vs. ZyVersa Therapeutics | Inozyme Pharma vs. Sonnet Biotherapeutics Holdings | Inozyme Pharma vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |